IMAC Holdings to Present at Fall Harvest – Best Ideas from the Buy-Side on October 5, 2021
29 September 2021 - 6:45AM
IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the
“Company”), a provider of innovative medical advancements and care
specializing in regenerative rehabilitation orthopedic treatments
without the use of surgery or opioids, has been invited to present
at the Fall Harvest – Best Ideas from the Buy-Side conference,
which is being held virtually starting October 5, 2021.
IMAC CEO Jeff Ervin is scheduled to present on
Tuesday, October 5 at 11:30 ET. Management will be
available for one-on-one meetings to be held throughout the
conference. Investors can register here. To receive additional
information, request an invitation or to schedule a one-on-one
meeting, please email angie.goertz@issuerdirect.com.
About the Fall Harvest -
Best Ideas from the Buy-Side
Conference
The Fall Harvest - MicroCap Rodeo is back with
its fourth “Best Ideas” conference. This conference is a virtual
conference that brings you the top 35 best ideas from the buy side.
Qualified institutional investors recommended each of the 35
companies represented as one of their best ideas. Those of you who
attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're
focused on alpha.
About IMAC Holdings, Inc.
IMAC Holdings owns and manages health and
wellness centers that deliver sports medicine, orthopedic, and life
science therapies for movement restricting diseases. IMAC is
comprised of three business segments: outpatient medical centers,
the BACKSPACE, and a clinical research division. With treatments to
address the aging population, IMAC Holdings owns or manages
more than 15 outpatient medical clinics and has partnered with
several active and former professional athletes, including Ozzie
Smith, David Price, Mike Ditka and Tony Delk to promote a
minimally-invasive approach to sports medicine. IMAC’s the
BACKSPACE retail spine health and wellness treatment centers
deliver chiropractic care within Walmart locations. IMAC’s research
division is currently conducting a Phase I clinical trial
evaluating a mesenchymal stem cell therapy candidate for
bradykinesia due to Parkinson’s disease. For more information visit
www.imacholdings.com
Contact:
IMAC Press Contact: Laura Fristoelfristoe@imacrc.com
Investor Relations:
Bret Shapiro(516) 222-2560brets@coreir.com
SOURCE: IMAC Holdings, Inc.
(Nasdaq: IMAC)
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Apr 2024 to May 2024
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about IMAC Holdings Inc (NASDAQ): 0 recent articles
More News Articles